Methyprylon
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Methyprylon?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Methyprylon, or Noludar, is a sedative of the piperidinedione derivative family first developed by Hoffmann-La Roche.[2] This medicine was used for treating insomnia, but is now rarely used as it has been replaced by newer drugs with fewer side effects, such as benzodiazepines.[3]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Dimerin, Methyprylone, Noctan, Noludar |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 60% |
Elimination half-life | 6-16 hours |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.315 |
Chemical and physical data | |
Formula | C10H17NO2 |
Molar mass | 183.251 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
NY (what is this?) (verify) |
Close
Methyprylon was withdrawn from the US market in June 1975 and the Canadian market in September 1990. Some other trade names are Noctan and Dimerin.